Daniel J. O'Connor
2018 - OncoSec Medical
In 2018, Daniel J. O'Connor earned a total compensation of $4.2M as President and Chief Executive Officer at OncoSec Medical.
Compensation breakdown
| Bonus | $70,136 |
|---|---|
| Option Awards | $3,819,000 |
| Salary | $283,078 |
| Other | $19,369 |
| Total | $4,191,583 |
O'Connor received $3.8M in option awards, accounting for 91% of the total pay in 2018.
O'Connor also received $70.1K in bonus, $283.1K in salary and $19.4K in other compensation.
Rankings
In 2018, Daniel J. O'Connor's compensation ranked 2,610th out of 14,244 executives tracked by ExecPay. In other words, O'Connor earned more than 81.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,610 out of 14,244 | 82nd |
Division Manufacturing | 961 out of 5,765 | 83rd |
Major group Chemicals And Allied Products | 327 out of 2,128 | 85th |
Industry group Drugs | 266 out of 1,817 | 85th |
Industry Pharmaceutical Preparations | 208 out of 1,391 | 85th |
Source: SEC filing on November 8, 2018.
O'Connor's colleagues
We found three more compensation records of executives who worked with Daniel J. O'Connor at OncoSec Medical in 2018.
News
OncoSec Medical CEO Daniel O'Connor's 2021 pay jumps 122% to $3M
May 31, 2022
OncoSec Medical CEO Daniel O'Connor's 2020 pay rises 15% to $1.4M
March 18, 2021
OncoSec Medical CEO Daniel O'Connor's 2019 pay falls 72% to $1.2M
April 30, 2020
OncoSec Medical CEO Daniel O'Connor's 2018 pay falls 39% to $4.2M
November 8, 2018